Soluble oligomers for the diagnosis of neurodegenerative diseases

Lancet Neurol. 2003 Aug;2(8):461-2. doi: 10.1016/s1474-4422(03)00481-2.
No abstract available

Publication types

  • Review

MeSH terms

  • Amyloid beta-Peptides / analysis
  • Amyloid beta-Peptides / biosynthesis
  • Animals
  • Brain / metabolism
  • Humans
  • Neurodegenerative Diseases / diagnosis*
  • Neurodegenerative Diseases / metabolism*
  • Peptide Fragments / analysis
  • Peptide Fragments / biosynthesis*
  • Solubility

Substances

  • Amyloid beta-Peptides
  • Peptide Fragments